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New Enzymes for New Alkaloids
PAGE 888
Madagascar periwinkle (Catharanthus roseus) produces several pharmaceutically impor-
tant terpene indole alkaloids. Metabolic engineering of the pathway that makes these
compounds is a promising strategy to generate novel molecules and potential new
drug candidates. However, reengineering efforts in this alkaloid system are limited by
the narrow substrate scope of the enzyme at the entry point of the pathway. Bernhardt
et al. report a strategy for rapid identification of enzyme variants that can be used to
expand the scope of alkaloid biosynthesis in one of Nature’s most prolific small-molecule
factories.
Inflammation: Glycodendrimers to the Rescue
PAGE 879
Synthetic, amine-functionalized heparin oligosaccharides can be attached to hyper-
branched macromolecules such as dendrimers to create novel heparin conjugates for
applications in glycobiology. As De Paz et al. report, the multivalent presentation of
heparin epitopes on the surface of dendrimers drastically amplifies the binding affinity
to heparin-binding proteins such as growth factors. Blocking interactions between
heparan sulfate and different protein families such as selectins and chemokines that
play a key role in inflammatory processesmaybeanother area of dendrimer application.
New anti-inflammatory drugs with minimal side effects may be based on synthetic
heparin dendrimers.
Stereocontrol of PKS Achieved by KR domains
PAGE 898
Polyketide synthases control the chiralities of multiple substituents during the synthesis of complex molecules like eryth-
romycin. The complicated architecture of these megasynthases has traditionally hindered efforts to determine how stereo-
control is achieved. Current structural and functional data of isolated ketoreductase domains presented by Keatinge-Clay
reveal that they are responsible for setting nearly all substituent chiralities. By comparing the structures of ketoreductases
that operate on the same substrate to yield different products, the mechanisms by which ketoreductases set unique
combinations of stereochemistries were elucidated. From this analysis, a protocol was developed to predict the structure
of a polyketide based on the sequence of its synthase.
Designing a MHC I Single Chain Trimer
PAGE 909
Due to their preassembled nature, MHC I single chain trimer (SCT) proteins bypass conventional antigen processing,
express efficiently at the cell surface, and potently stimulate CD8 T cells in vivo. These properties afford us a unique
opportunity to broaden the production of antigen-specific DNA vaccines to include the induction of subdominant immune
responses. Mitaksov et al. present a novel approach for generating soluble covalently linked pMHC reagents that is based
on coupling of peptide and class I HC using covalent disulfide bond trapping. The produced disulfide-trap SCT and soluble
pMHC reagents are potential diagnostic tools and modulators of T cell responses to pathogens and tumors.Chemistry & Biology 14, August 2007 ª2007 Elsevier Ltd All rights reserved ix
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Reactive oxygen species (ROS) cause cellular damage and are implicated in hu-
man illness ranging from cancer to Alzheimer’s disease. While the effects of ROS
have been studied in depth within living systems, little is known about how the
subcellular origin of ROS impacts the cellular response. In order to develop
a clearer picture, a set of chemical tools were engineered that allowed oxidative
stress to be studied in specific organelles. By delivering oxidant-bearing peptide
conjugates specifically to mitochondria or nuclei, oxidative stress was generated
site-specifically. It was found that the specific organelle targeted by oxidative
stress influences significantly the viability of the cell and the nature of the cell’s
stress response. These comparative studies, enabled by the development of
organelle-specific oxidants, are the first to examine cellular responses to site-
specific oxidative stress.
Mechanism of Pikromycin PKS Product Partioning
PAGE 944
Polyketide natural products are renowned for their architecturally complex chemical structures and diverse bioactivity.
Accordingly, there is considerable interest in generating novel natural product molecules through manipulation and engi-
neering of metabolic pathways for polyketide biosynthesis. The pikromycin polyketide synthase (PKS) is unprecedented
in its ability to generate both 12- and 14-membered ring macrolactone products. Kittendorf et al. investigated possible
mechanisms responsible for this unusual product partitioning. The results of this comprehensive in vitro study demonstrate
that the docking domain-mediated protein-protein interaction between the final two monomodules of the pikromcyin PKS
is a requirement for assembly of both macrolactone products.
Engineering Polyketide Synthase: Structure
Paves the Way
PAGE 931
Tang et al. report the 2.6-A˚ X-ray crystal structure of a 190-kDa homodimeric
fragment from module 3 of the 6-deoxyerthronolide B synthase. Its ketosynthase
domain is covalently bound to the inhibitor cerulenin. The overall structure reveals
two well-organized catalytic domains and two interdomain linker regions. In
conjunction with other mechanistic results, the authors propose a model for the
interaction of the catalytic domains with the acyl carrier protein (ACP) domain.
These results pave the way for structure-based engineering of polyketide
synthases.
Mutasynthetic Approach Leads to Natural
Product Diversification
PAGE 955
The study by Anderle et al. reports improved mutasynthetic approaches for the production of aminocoumarin antibiotics.
The versatility of mutasynthesis was significantly improved by metabolic engineering of the producer strains using
heterologous genes that code for enzymeswith suitable substrate specificities, as well as by two-stage feeding procedures
in which two different mutant strains are used in succession. These methods offer the potential to significantly increase the
structural diversity of natural products obtainable by mutasynthesis experiments in drug discovery programs.x Chemistry & Biology 14, August 2007 ª2007 Elsevier Ltd All rights reserved
